Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2023	Sep. 30, 2022
Current Assets:
Cash and cash equivalents	$ 41,419	$ 18,998
Available-for-sale securities	3,933
Accounts receivable, net of allowances of $80 and $81 as of September 30, 2023 and 2022, respectively	10,850	10,452
Contract assets — royalties and license fees	7,796	7,116
Inventories, net	14,839	11,819
Income tax receivable	491	2,438
Prepaids and other	7,363	6,764
Total Current Assets	86,691	57,587
Property and equipment, net	26,026	27,148
Intangible assets, net	26,206	28,145
Goodwill	42,946	40,710
Other assets	3,864	4,769
Total Assets	185,733	158,359
Current Liabilities:
Accounts payable	2,993	3,136
Accrued liabilities:
Compensation	10,139	8,929
Accrued other	6,444	5,854
Short-term borrowings		10,000
Deferred revenue	4,378	4,160
Total Current Liabilities	23,954	32,079
Long-term debt, net	29,405
Deferred revenue, less current portion	2,400	5,088
Deferred income taxes	2,004	2,027
Other long-term liabilities	8,060	10,773
Total Liabilities	65,823	49,967
Commitments and Contingencies (Note 11)
Stockholders’ Equity:
Series A preferred stock — $.05 par value, 450 shares authorized; no shares issued and outstanding
Common stock - $.05 par value, 45,000 shares authorized; 14,155 and 14,029 shares issued and outstanding, as of September 30, 2023 and 2022, respectively	708	701
Additional paid-in capital	36,706	28,774
Accumulated other comprehensive loss	(4,759)	(9,874)
Retained earnings	87,255	88,791
Total Stockholders’ Equity	119,910	108,392
Total Liabilities and Stockholders’ Equity	$ 185,733	$ 158,359